Millipore Presents: Innovations And Challenges For Sterilizing-Grade Technologies

September 24th Open House Event Recognizes Millipore's 30 Years of Sterility Assurance

WHEN: September 24, 2009
9:45AM – 3:30 PM

WHERE: Millipore Corporation
Manufacturing Facility
Prescott Road
Jaffrey, NH 03452

WHAT:

• Distinguished industry experts will address the importance of sterilizing-grade technologies and the opportunities as well as challenges bioprocessing companies are faced with today.
• QA and regulatory experts from GlaxoSmithKline and the FDA will talk about the current state and future of aseptic processing.
• Opportunity for customers and media to ask questions during the roundtable discussion.
• See first-hand how Millipore's sterilization solutions are produced during an informative tour of our worldwide center for Bioprocess manufacturing. Operations in Jaffrey have grown significantly over the last few years, with completion of a state-of-the-art ultra-filtration membrane plant and new warehousing facility.

INTERVIEW OPPORTUNITIES
Martin D. Madaus, Chairman of the Board, President and CEO
Jean-Paul Mangeolle, President, Bioprocess Division
Maurice G. Phelan, Director, Global Compliance Services and Regulatory Affairs
Mitch Fonda, Director, Manufacturing Operations
Pete Eichert, Jaffrey Site Quality Systems Manager

EVENT REGISTRATION
Please visit: http://www.millipore.com/september24.

About MILLIPORE
Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with 6,000 employees in 47 countries worldwide. For more information, visit www.millipore.com.

SOURCE: MILLIPORE